Ethoxyquin → Retinol

HRID 987358

반응식

[CH3:1][C:2]1[CH2:7][CH2:6][CH2:5][C:4]([CH3:9])([CH3:8])[C:3]=1/[CH:10]=[CH:11]/[C:12](/[CH3:24])=[CH:13]/[CH:14]=[CH:15]/[C:16](/[CH3:23])=[CH:17]/[CH2:18][O:19]C(C)=O.CCOC1C=C2C(C)=CC(C)(C)NC2=CC=1>>[CH3:1][C:2]1[CH2:7][CH2:6][CH2:5][C:4]([CH3:8])([CH3:9])[C:3]=1/[CH:10]=[CH:11]/[C:12](/[CH3:24])=[CH:13]/[CH:14]=[CH:15]/[C:16](/[CH3:23])=[CH:17]/[CH2:18][OH:19]

참가 물질

반응물 2

HCID 3293Ethoxyquin

HCID 638034Retinol, acetate

생성물 1

HCID 445354Retinol

실험 절차

mixture of vitamin A acetate, 2.8 million IU/G unstab. (80% by weight) (BASF AG) and ethoxyquin (20% by weight) (Raluquin, Raschig AG) were run in at 60° C. via a heated pump unit.

후처리

customwere run in at 60° C. via a heated pump unit

출처 및 근거

ORD 기록: ord-ef3ee44cf5574abaa8a8c7601bd53396
출처 데이터셋: uspto-grants-2003_10
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06632389B1

연결된 노트

불러오는 중…